The Maldives Food and Drug Authority (MFDA) has issued a warning for consumers to be cautious of 48 drugs manufactured by Indian pharmaceutical companies, citing quality concerns.

Among the flagged medications is paracetamol, a commonly used children's drug.

The MFDA has raised these concerns with India's Central Drugs Standard Control Organization (CDSCO).

Following this alert, the MFDA conducted checks in local pharmacies and confirmed that none of the drugs on the CDSCO list are currently available in the Maldivian market.

One drug, which had been approved in 2017, has not been imported since 2018.

However, the MFDA urged caution, noting that many Maldivians seek medical treatment in India and may personally bring medications back into the country.

The authority also emphasized its commitment to strengthening inspections at ports to prevent the entry of such drugs.

For more information, the MFDA has provided a hotline number (7200321) for inquiries.

The MFDA has shared the complete details of the flagged drugs on its social media platform X to raise public awareness.